303 related articles for article (PubMed ID: 29275334)
1. Effect of rituximab on a salivary gland ultrasound score in primary Sjögren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy.
Fisher BA; Everett CC; Rout J; O'Dwyer JL; Emery P; Pitzalis C; Ng WF; Carr A; Pease CT; Price EJ; Sutcliffe N; Makdissi J; Tappuni AR; Gendi NST; Hall FC; Ruddock SP; Fernandez C; Hulme CT; Davies KA; Edwards CJ; Lanyon PC; Moots RJ; Roussou E; Richards A; Sharples LD; Bombardieri M; Bowman SJ
Ann Rheum Dis; 2018 Mar; 77(3):412-416. PubMed ID: 29275334
[TBL] [Abstract][Full Text] [Related]
2. Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment.
Delli K; Haacke EA; Kroese FG; Pollard RP; Ihrler S; van der Vegt B; Vissink A; Bootsma H; Spijkervet FK
Ann Rheum Dis; 2016 Nov; 75(11):1933-1938. PubMed ID: 26757748
[TBL] [Abstract][Full Text] [Related]
3. Brief Report: Ultrasonographic Assessment of Salivary Gland Response to Rituximab in Primary Sjögren's Syndrome.
Jousse-Joulin S; Devauchelle-Pensec V; Cornec D; Marhadour T; Bressollette L; Gestin S; Pers JO; Nowak E; Saraux A
Arthritis Rheumatol; 2015 Jun; 67(6):1623-8. PubMed ID: 25708147
[TBL] [Abstract][Full Text] [Related]
4. Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjögren's syndrome.
Cornec D; Costa S; Devauchelle-Pensec V; Jousse-Joulin S; Marcorelles P; Berthelot JM; Chiche L; Hachulla E; Hatron PY; Goeb V; Vittecoq O; Saraux A; Pers JO
J Autoimmun; 2016 Feb; 67():102-110. PubMed ID: 26688003
[TBL] [Abstract][Full Text] [Related]
5. The TRACTISS protocol: a randomised double blind placebo controlled clinical trial of anti-B-cell therapy in patients with primary Sjögren's Syndrome.
Brown S; Navarro Coy N; Pitzalis C; Emery P; Pavitt S; Gray J; Hulme C; Hall F; Busch R; Smith P; Dawson L; Bombardieri M; Wan-Fai N; Pease C; Price E; Sutcliffe N; Woods C; Ruddock S; Everett C; Reynolds C; Skinner E; Poveda-Gallego A; Rout J; Macleod I; Rauz S; Bowman S;
BMC Musculoskelet Disord; 2014 Jan; 15():21. PubMed ID: 24438039
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and predictive evaluation using salivary gland ultrasonography in primary Sjögren's syndrome.
Lee KA; Lee SH; Kim HR
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):165-172. PubMed ID: 29600950
[TBL] [Abstract][Full Text] [Related]
7. Salivary gland ultrasound in the diagnostic workup of juvenile Sjögren's syndrome and mixed connective tissue disease.
Krumrey-Langkammerer M; Haas JP
Pediatr Rheumatol Online J; 2020 Jun; 18(1):44. PubMed ID: 32517804
[TBL] [Abstract][Full Text] [Related]
8. A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome.
Juarez M; Diaz N; Johnston GI; Nayar S; Payne A; Helmer E; Cain D; Williams P; Devauchelle-Pensec V; Fisher BA; Giacomelli R; Gottenberg JE; Guggino G; Kvarnström M; Mariette X; Ng WF; Rosas J; Sánchez Bursón J; Triolo G; Barone F; Bowman SJ
Rheumatology (Oxford); 2021 Mar; 60(3):1364-1375. PubMed ID: 32949140
[TBL] [Abstract][Full Text] [Related]
9. Salivary gland ultrasonography: a highly specific tool for the early diagnosis of primary Sjögren's syndrome.
Baldini C; Luciano N; Tarantini G; Pascale R; Sernissi F; Mosca M; Caramella D; Bombardieri S
Arthritis Res Ther; 2015 May; 17(1):146. PubMed ID: 26022533
[TBL] [Abstract][Full Text] [Related]
10. Ultrasonographic evaluation of major salivary glands in primary Sjögren's syndrome: comparison of two scoring systems.
Zhang X; Zhang S; He J; Hu F; Liu H; Li J; Zhu J; Li Z
Rheumatology (Oxford); 2015 Sep; 54(9):1680-7. PubMed ID: 25936787
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial.
Bowman SJ; Fox R; Dörner T; Mariette X; Papas A; Grader-Beck T; Fisher BA; Barcelos F; De Vita S; Schulze-Koops H; Moots RJ; Junge G; Woznicki JN; Sopala MA; Luo WL; Hueber W
Lancet; 2022 Jan; 399(10320):161-171. PubMed ID: 34861168
[TBL] [Abstract][Full Text] [Related]
12. Salivary gland ultrasonography in primary Sjögren's syndrome from diagnosis to clinical stratification: a multicentre study.
Zhang X; Feng R; Zhao J; Wang Y; He J; Liu L; Cheng Y; Yao H; Tang S; Chen J; Zhang S; Zhang Z; Wang Q; He J; Li Z
Arthritis Res Ther; 2021 Dec; 23(1):305. PubMed ID: 34930431
[TBL] [Abstract][Full Text] [Related]
13. NKp30 Receptor Upregulation in Salivary Glands of Sjögren's Syndrome Characterizes Ectopic Lymphoid Structures and Is Restricted by Rituximab Treatment.
Pontarini E; Sciacca E; Grigoriadou S; Rivellese F; Lucchesi D; Fossati-Jimack L; Coleby R; Chowdhury F; Calcaterra F; Tappuni A; Lewis MJ; Fabris M; Quartuccio L; Bella SD; Bowman S; Pitzalis C; Mavilio D; De Vita S; Bombardieri M
Front Immunol; 2021; 12():706737. PubMed ID: 34594326
[TBL] [Abstract][Full Text] [Related]
14. Weight of salivary gland ultrasonography compared to other items of the 2016 ACR/EULAR classification criteria for Primary Sjögren's syndrome.
Jousse-Joulin S; Gatineau F; Baldini C; Baer A; Barone F; Bootsma H; Bowman S; Brito-Zerón P; Cornec D; Dorner T; de Vita S; Fisher B; Hammenfors D; Jonsson M; Mariette X; Milic V; Nakamura H; Ng WF; Nowak E; Ramos-Casals M; Rasmussen A; Seror R; Shiboski CH; Nakamura T; Vissink A; Saraux A; Devauchelle-Pensec V
J Intern Med; 2020 Feb; 287(2):180-188. PubMed ID: 31618794
[TBL] [Abstract][Full Text] [Related]
15. Salivary gland ultrasound findings are associated with clinical and serologic features in primary Sjögren's syndrome patients.
Silva JL; Faria DS; Neves JS; Cerqueira M; Peixoto D; Teixeira F
Acta Reumatol Port; 2020; 45(1):76-77. PubMed ID: 32608383
[TBL] [Abstract][Full Text] [Related]
16. Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome.
Bowman SJ; Everett CC; O'Dwyer JL; Emery P; Pitzalis C; Ng WF; Pease CT; Price EJ; Sutcliffe N; Gendi NST; Hall FC; Ruddock SP; Fernandez C; Reynolds C; Hulme CT; Davies KA; Edwards CJ; Lanyon PC; Moots RJ; Roussou E; Giles IP; Sharples LD; Bombardieri M
Arthritis Rheumatol; 2017 Jul; 69(7):1440-1450. PubMed ID: 28296257
[TBL] [Abstract][Full Text] [Related]
17. Persistence of immunoglobulin-producing cells in parotid salivary glands of patients with primary Sjögren's syndrome after B cell depletion therapy.
Hamza N; Bootsma H; Yuvaraj S; Spijkervet FK; Haacke EA; Pollard RP; Visser A; Vissink A; Kallenberg CG; Kroese FG; Bos NA
Ann Rheum Dis; 2012 Nov; 71(11):1881-7. PubMed ID: 22615459
[TBL] [Abstract][Full Text] [Related]
18. Primary Sjögren's syndrome: diagnostic and prognostic value of salivary gland ultrasonography using a simplified scoring system.
Theander E; Mandl T
Arthritis Care Res (Hoboken); 2014 Jul; 66(7):1102-7. PubMed ID: 24339361
[TBL] [Abstract][Full Text] [Related]
19. Ultrasonographic characteristics of major salivary glands in anti-centromere antibody-positive primary Sjögren's syndrome.
Min HK; Kim SH; Park Y; Lee KA; Kwok SK; Lee SH; Kim HR
PLoS One; 2021; 16(11):e0259519. PubMed ID: 34731207
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study.
Carubbi F; Cipriani P; Marrelli A; Benedetto P; Ruscitti P; Berardicurti O; Pantano I; Liakouli V; Alvaro S; Alunno A; Manzo A; Ciccia F; Gerli R; Triolo G; Giacomelli R
Arthritis Res Ther; 2013 Oct; 15(5):R172. PubMed ID: 24286296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
